Logotipo do repositório
 

Publicação:
Liquid crystalline formulations containing modified surface TiO2 nanoparticles obtained by sol-gel process

dc.contributor.authorManaia, Eloisa Berbel [UNESP]
dc.contributor.authorKiatkoski Kaminski, Renata Cristina [UNESP]
dc.contributor.authorSoares, Christiane Pienna [UNESP]
dc.contributor.authorMeneau, Florian
dc.contributor.authorPulcinelli, Sandra Helena [UNESP]
dc.contributor.authorSantilli, Celso Valentim [UNESP]
dc.contributor.authorChiavacci, Leila Aparecida [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionSynchrotron SOLEIL LOrme Merisiers
dc.date.accessioned2014-05-20T14:18:17Z
dc.date.available2014-05-20T14:18:17Z
dc.date.issued2012-08-01
dc.description.abstractTitanium dioxide (TiO2) is an inorganic compound used as sunscreen in cosmetic/pharmaceutical formulations as a way to prevent the skin cancer. In this work we have used surface modified titania nanoparticles obtained by thermo-reversible sol-gel transition showing transparency in the range of temperature typical for sunscreen use (between 20 and 45 A degrees C). The goal of this work was to develop and characterize liquid crystalline cosmetic formulations containing surface modified titania nanoparticles. We have analyzed the citotoxicity of the nanoparticles, their zeta potential and the liquid crystalline phase behavior of the formulations. The violet crystal assay has shown no citotoxicity associated to the presence of surface modified groups on the two cell lines tested, human keratinocytes and fibroblasts, presenting more than 70% of cell viability for all analyzed nanoparticles. The zeta potential measurements revealed a negative charged surface for TiO2 nanoparticles at pH values in the range of 6.5-7.0, preventing the aggregation and maintaining the final transparency of the liquid crystalline sunscreen formulations. The polarized light microscopy, associated to SAXS, have shown the presence of liquid crystalline phases both with and without TiO2 nanoparticles. The charged surface of TiO2 nanoparticles maintains the stability of the formulations and the liquid crystalline structure. This renders this system a good candidate for being used simultaneously as sunscreen and as controlled release system of anti cancer drugs.en
dc.description.affiliationUNESP, São Paulo State Univ, Sch Pharmaceut Sci, Araraquara, SP, Brazil
dc.description.affiliationUNESP, São Paulo State Univ, Inst Chem, Araraquara, SP, Brazil
dc.description.affiliationSynchrotron SOLEIL LOrme Merisiers, F-91192 Gif Sur Yvette, France
dc.description.affiliationUnespUNESP, São Paulo State Univ, Sch Pharmaceut Sci, Araraquara, SP, Brazil
dc.description.affiliationUnespUNESP, São Paulo State Univ, Inst Chem, Araraquara, SP, Brazil
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipPrograma de Apoio ao Desenvolvimento Científico da Faculdade de Ciências Farmacêuticas da UNESP (PADC)
dc.format.extent251-257
dc.identifierhttp://dx.doi.org/10.1007/s10971-011-2673-7
dc.identifier.citationJournal of Sol-gel Science and Technology. Dordrecht: Springer, v. 63, n. 2, p. 251-257, 2012.
dc.identifier.doi10.1007/s10971-011-2673-7
dc.identifier.issn0928-0707
dc.identifier.lattes9971202585286967
dc.identifier.lattes5584298681870865
dc.identifier.lattes1768025290373669
dc.identifier.orcid0000-0002-8356-8093
dc.identifier.orcid0000-0003-1740-7360
dc.identifier.urihttp://hdl.handle.net/11449/25503
dc.identifier.wosWOS:000306846700009
dc.language.isoeng
dc.publisherSpringer
dc.relation.ispartofJournal of Sol-Gel Science and Technology
dc.relation.ispartofjcr1.745
dc.relation.ispartofsjr0,477
dc.rights.accessRightsAcesso restritopt
dc.sourceWeb of Science
dc.subjectTiO2en
dc.subjectSol-gel processen
dc.subjectLiquid crystalen
dc.subjectDrug deliveryen
dc.titleLiquid crystalline formulations containing modified surface TiO2 nanoparticles obtained by sol-gel processen
dc.typeArtigopt
dcterms.licensehttp://www.springer.com/open+access/authors+rights?SGWID=0-176704-12-683201-0
dcterms.rightsHolderSpringer
dspace.entity.typePublication
relation.isDepartmentOfPublicationa83d26d6-5383-42e4-bb3c-2678a6ddc144
relation.isDepartmentOfPublicatione214da1b-9929-4ae9-b8fd-655e9bfeda4b
relation.isDepartmentOfPublication.latestForDiscoverya83d26d6-5383-42e4-bb3c-2678a6ddc144
relation.isOrgUnitOfPublication95697b0b-8977-4af6-88d5-c29c80b5ee92
relation.isOrgUnitOfPublication.latestForDiscovery95697b0b-8977-4af6-88d5-c29c80b5ee92
unesp.author.lattes9971202585286967
unesp.author.lattes5584298681870865[6]
unesp.author.lattes1768025290373669[3]
unesp.author.orcid0000-0002-8356-8093[6]
unesp.author.orcid0000-0003-1740-7360[3]
unesp.campusUniversidade Estadual Paulista (UNESP), Instituto de Química, Araraquarapt
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquarapt
unesp.departmentAnálises Clínicas - FCFpt
unesp.departmentFármacos e Medicamentos - FCFpt
unesp.departmentFísico-Química - IQARpt

Arquivos

Licença do Pacote

Agora exibindo 1 - 2 de 2
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: